UTEP launches clinical trial to improve community health through walking

FHS
March 6, 2024
5:07 pm

Health researchers at The University of Texas at El Paso are launching a clinical trial to improve walking in the El Paso community, thanks to a $4.4 million grant from the National Institutes of Health.

Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression

Cybin Inc. CYBN has completed enrollment in its Phase 2 study of novel deuterated psilocybin analog CYB003 for the potential treatment of Major Depressive Disorder (MDD.)

September 22, 2023

NIH funding supports innovative lupus research using DNA mimic molecules

Lupus causes chronic pain, fatigue, and potentially organ damage for 1.5 million Americans and is a challenge for researchers trying to find better treatments.

December 12, 2024

CVS Pulls Phenylephrine Cold Meds; Doc’s Murder/Suicide; Red Meat and Diabetes

Note that some links may require registration or subscription. CVS will stop selling widely used non-prescription cold medicines that contain the decongestant phenylephrine, a decision

October 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.